NeuroSense Granted Patents in Europe, Japan, and Israel for its ALS Drug PrimeC

Patents valid through 2038 Clinical topline results from Phase 2b ALS trial expected in H2 2023 Corresponding patents have b...

September 21, 2023 | Thursday | News
European Commission Approves ORSERDU® for ER+ Breast Cancer with ESR1 Mutation

Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...

September 14, 2023 | Thursday | News
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced  that the European Unified Patent Court ("UPC") issued a...

September 20, 2023 | Wednesday | News
Baird Medical's Sterile Biopsy Needle Gains Approval from Jiangsu Medical Products Administration in China.

Baird Medical's MWA products have been available in China for many years, and the Company is known as a market leader in MWA technology for thyroid and bre...

September 06, 2023 | Wednesday | News
MedAlliance Enrolls First Patient in SELUTION SLR LOVE-DEB Coronary Study

The aim of the LOVE-DEB Study (Large de-NOVo coronary artEry disease treated with sirolimus Drug Eluting Balloon: prospective evaluation of safety & ef...

September 06, 2023 | Wednesday | News
Pfizer-BioNTech's Omicron-adapted COVID-19 Vaccine Gets Positive CHMP Opinion in EU

 The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age a...

September 04, 2023 | Monday | News
ENHERTU® Earns Dual Breakthrough Therapy Designations for HER2-Expressing Cancers in the U.S

Designations for Daiichi Sankyo and AstraZeneca's ENHERTU include patients with HER2 expressing metastatic solid tumors and HER2 positive metastatic colo...

September 04, 2023 | Monday | News
23andMe Granted New FDA Clearance to Report Additional BRCA Variants

510(k) clearance will allow 23andMe to report an additional 41 genetic variants in the BRCA1 and BRCA2 genes that increase risk for breast, ovarian, prosta...

September 01, 2023 | Friday | News
Asieris Receives NMPA IND Approval for APL-1401 in Ulcerative Colitis

The study is a randomized, double-blind Phase Ib study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of APL-1401 in patie...

August 30, 2023 | Wednesday | News
EU Approves Roche's Evrysdi for Infants Under Two Months with SMA

Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1 Approval is based on interim data from ongoin...

August 29, 2023 | Tuesday | News
AstraZeneca Calls for Review of Inflation Reduction Act's Impact on US Patients

To help protect access to medicines for cancer and rare disease patients, AstraZeneca  has filed a legal challenge to critical aspects of the drug pri...

August 28, 2023 | Monday | News
GE Introduces Vscan Air SL: Handheld Wireless Ultrasound for Quick Cardiac Assessments

With a dual-headed probe, the Vscan Air SL offers a sector array and a linear array on a single device which is ideal for switching between focused cardi...

August 28, 2023 | Monday | News
ADVENT Study Shows Success of FARAPULSE™ Ablation System

Boston Scientific Corporation (NYSE: BSX)  announced positive 12-month results from the pivotal ADVENT clinical trial of the FARAPULSE™ Pulsed F...

August 28, 2023 | Monday | News
Agilent Receives European IVDR Certification for Companion Diagnostic Assay

PD-L1 IHC 22C3 pharmDx, Code SK006, is indicated as an aid in identifying certain cancer patients for treatment with KEYTRUDA® (pembrolizumab), Merck&r...

August 25, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in